Kenvue Inc. (NYSE:KVUE) Receives $20.23 Consensus Price Target from Brokerages

Kenvue Inc. (NYSE:KVUE) has been assigned an average rating of “Hold” from the eighteen analysts that are currently covering the firm, Marketbeat Ratings reports. Twelve equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12 month target price among brokers that have covered the stock in the last year is $20.2333.

Several equities analysts have recently issued reports on KVUE shares. Weiss Ratings reissued a “hold (c-)” rating on shares of Kenvue in a research note on Tuesday, October 14th. Canaccord Genuity Group reiterated a “hold” rating and issued a $15.00 price target (down previously from $26.00) on shares of Kenvue in a report on Wednesday, October 29th. Zacks Research upgraded shares of Kenvue from a “strong sell” rating to a “hold” rating in a report on Wednesday, November 26th. Deutsche Bank Aktiengesellschaft set a $18.00 target price on shares of Kenvue in a research report on Friday, October 24th. Finally, Rothschild & Co Redburn upgraded shares of Kenvue from a “neutral” rating to a “buy” rating and reduced their price target for the company from $22.50 to $22.00 in a research report on Friday, September 26th.

Insider Activity

In other news, Director Jeffrey C. Smith bought 3,200,000 shares of the stock in a transaction dated Friday, December 12th. The stock was bought at an average price of $17.37 per share, for a total transaction of $55,584,000.00. Following the purchase, the director directly owned 27,307,632 shares in the company, valued at $474,333,567.84. This trade represents a 13.27% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.68% of the company’s stock.

Institutional Investors Weigh In On Kenvue

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vident Advisory LLC bought a new stake in shares of Kenvue during the 1st quarter valued at $520,000. Alliancebernstein L.P. boosted its stake in Kenvue by 15.3% during the first quarter. Alliancebernstein L.P. now owns 2,982,269 shares of the company’s stock worth $71,515,000 after acquiring an additional 395,785 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Kenvue by 1.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 214,714 shares of the company’s stock worth $5,138,000 after acquiring an additional 3,429 shares in the last quarter. Nissay Asset Management Corp Japan ADV grew its holdings in Kenvue by 1.4% in the first quarter. Nissay Asset Management Corp Japan ADV now owns 232,441 shares of the company’s stock worth $5,574,000 after purchasing an additional 3,169 shares during the period. Finally, Third Point LLC bought a new position in shares of Kenvue during the first quarter valued at approximately $213,422,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Kenvue Stock Performance

Shares of NYSE:KVUE opened at $17.00 on Friday. The company has a market cap of $32.56 billion, a price-to-earnings ratio of 22.66 and a beta of 0.60. The company has a 50-day moving average price of $16.85 and a 200-day moving average price of $18.45. The company has a current ratio of 0.98, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. Kenvue has a 12 month low of $14.02 and a 12 month high of $25.17.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Monday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. The company had revenue of $3.76 billion for the quarter, compared to the consensus estimate of $3.83 billion. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.Kenvue’s revenue was down 3.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.28 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, equities analysts anticipate that Kenvue will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, November 26th. Shareholders of record on Wednesday, November 12th were issued a dividend of $0.2075 per share. The ex-dividend date was Wednesday, November 12th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.9%. Kenvue’s dividend payout ratio is 110.67%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.